Myriad Genetics Inc
XBER:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
XBER:MYD
|
US |
|
Y
|
Yankuang Energy Group Co Ltd
XBER:YZCA
|
CN |
|
Lynas Rare Earths Ltd
ASX:LYC
|
MY |
|
Ecovyst Inc
NYSE:ECVT
|
US |
|
A
|
Archer Aviation Inc
NYSE:ACHR
|
US |
|
D
|
Dover Corp
LSE:0ICP
|
US |
|
Redcare Pharmacy NV
F:SAE1
|
NL |
|
Ascencio SCA
XBRU:ASCE
|
BE |
|
M
|
MakeMyTrip Ltd
F:MY1
|
IN |
|
S
|
Schlumberger NV
SIX:SLB
|
US |
|
H
|
Hochtief AG
XHAM:HOT
|
DE |
|
M
|
Myriad Genetics Inc
XMUN:MYD
|
US |
|
C
|
Canon Marketing Japan Inc
XMUN:CNJ
|
JP |
|
H
|
HP Inc
LSE:0J2E
|
US |
|
H
|
Hisense Home Appliances Group Co Ltd
F:GKE
|
CN |
|
R
|
Redcare Pharmacy NV
DUS:RDC
|
NL |
|
P
|
Post Holdings Inc
F:2PO
|
US |
|
Welcia Holdings Co Ltd
TSE:3141
|
JP |
|
N
|
Natural Grocers By Vitamin Cottage Inc
SWB:N2V
|
US |
Bankruptcy Probability
Myriad Genetics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Myriad Genetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
584.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
200.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Myriad Genetics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Myriad Genetics Inc has total debt of 120.3m USD. This includes both short-term (0 USD) and long-term (120.3m USD) debt.
You can find a full breakdown on its Balance Sheet.
